Sponsor:
Rutgers, The State University of New Jersey
Code:
NCT03729713
Conditions
Multiple Sclerosis
Cognitive Impairment
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Computerized cognitive rehabilitation
Sham placebo
Brief summary:
Conditions
Multiple Sclerosis
Cognitive Impairment
Study ID
NCT03729713
Start date
Apr 21, 2021
Status verified date
Nov, 2022
Completion date
May, 2024
Anticipated
Primary completion date
May, 2023
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Enrollment
80 participants
Anticipated
Allocation
Randomized
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Intervention
sham comparator: Placebo
Interventions
Computerized cognitive rehabilitation
Sham placebo
Primary outcome measure
Central contacts
Locations
Robert Wood Johnson Medical School
Recruiting
New Brunswick, New Jersey, United States, 08091
Contacts
Vikram Bhise, MD
732-235-7875Principal Investigator:
Vikram Bhise, MD
Sponsor
Rutgers, The State University of New Jersey
Last update posted
Nov 17, 2022
Last verified
Nov, 2022
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Rutgers, The State University of New Jersey on 2022-11-17.